BioAge Labs, Inc. (BIOA) News
Follow BioAge Labs, Inc. (BIOA) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 9 public stories across 5 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Roth Capital maintains $25 price target on BioAge Labs
Roth Capital maintained its price target of $25.00 per share for BioAge Labs, according to Benzinga’s ratings actions.
EQUITY | Sep 09, 2026, 05:56 PM UTC
L
BIOA advances BGE-102 to two Phase II trials for DME
BIOA said BGE-102 has advanced to two Phase II trials, including DME, with “strong biomarker and safety data.” The oral therapy targets ophthalmology and metabolic disease needs; pivotal data is expected next year.
EQUITY | Sep 09, 2026, 05:25 PM UTC
L
BIOA advances Phase II oral NLRP3 inhibitor trials, pivotal data targeted
BIOA’s BGE-102 moved into two Phase II trials after Phase I, with results tied to biomarker readouts. The company is expanding into ophthalmology (including DME) and expects key data readouts by year-end and next year.
EQUITY | Sep 09, 2026, 04:46 PM UTC
L
BTIG maintains BioAge Labs $40 price target
BTIG maintained a $40.00/share price target for BioAge Labs, according to Benzinga ratings actions.
EQUITY | Sep 08, 2026, 03:35 PM UTC
L
BioAge Labs doses first participant in QUELL-DME Phase 2
BioAge Labs says the first participant was dosed in QUELL-DME, a Phase 2 trial of BGE-102 in diabetic macular edema.
EQUITY | Sep 08, 2026, 12:02 PM UTC
L
BioAge Labs to present at upcoming investor conferences
BioAge Labs said it will present at upcoming investor conferences, according to a company announcement from Emeryville, California.
EQUITY | Sep 02, 2026, 12:07 PM UTC
L
BIOA - BioAge Labs to Present at Upcoming Investor Conferences
BIOA - BioAge Labs to Present at Upcoming Investor Conferences
EQUITY | Sep 02, 2026, 12:01 PM UTC
L
BIOA B BIOA - Number of shares and votes in BioArctic AB (publ) as of August 31, 2026
BIOA B BIOA - Number of shares and votes in BioArctic AB (publ) as of August 31, 2026
EQUITY | Aug 31, 2026, 03:57 PM UTC
L
BIOA - BioAge Labs Reports Second Quarter 2026 Financial Results and Provides Business Updates
BIOA - BioAge Labs Reports Second Quarter 2026 Financial Results and Provides Business Updates
EARNINGS | Aug 05, 2026, 08:50 PM UTC